NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ASTX - Astex Pharmaceuticals Inc

Astex Pharmaceuticals, Inc., formerly SuperGen, Inc., incorporated in March 1991, is a pharmaceutical company engaged primarily in the discovery and development of therapies to treat patients with cancer. The Company acquires products developed by other companies and applies additional developmental effort to expand sales or advance these products clinically towards approval for marketing. The Company’s primary de","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ASTXhart

Astex Pharmaceuticals Inc News


Astex Pharmaceuticals to Present at ASCO Annual Meeting
MarketWatch (press release) - May 16, 2012
DUBLIN, Calif., May 16, 2012 (GlobeNewswire via COMTEX) -- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) , a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the acceptance of three ...

5 Reasons To Buy Astex Pharmaceuticals
Seeking Alpha - May 13, 2012
Astex Pharmaceuticals (ASTX) is a leader in innovative drug discovery, development and commercialization, and is committed to the fight against cancer and other life-threatening diseases.

Top Gainers in After-hours Today, Apr-30
Fyxnews - Apr 30, 2012
Astex Pharmaceuticals Inc. (NASDAQ:ASTX) is currently trading at $1.85 up 4.5% in after-hours on 5300 shares traded. ASTX is trading -2.07% below its 50 day moving average and -12.96% below its 200 day moving average. ASTX is -47.16% below its 52-week ...

Astex Pharmaceuticals Reports 2012 First Quarter Financial Results
MarketWatch (press release) - Apr 30, 2012
DUBLIN, Calif., April 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) , today reported financial results for the first quarter ended March 31, 2012.
Astex Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript - Seeking Alpha

Astex focused on creating value for investors in 2012
Proactive Investors USA & Canada - Apr 27, 2012
Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), the pharmaceutical company dedicated to discovering and devloping novel small molecule therapeutics, just announced that it will release its 2012 first quarter financial results on Monday, April 30, 2012.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>